33
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Timely administration of antibiotics is one of the most important interventions in reducing mortality in sepsis. However, administering antibiotics within a strict time threshold in all patients suspected with sepsis will require huge amount of effort and resources and may increase the risk of unintentional exposure to broad-spectrum antibiotics in patients without infection with its consequences. Thus, controversy still exists on whether clinicians should target different time-to-antibiotics thresholds for patients with sepsis versus septic shock.

          Methods

          This study analyzed prospectively collected data from an ongoing multicenter cohort of patients with sepsis identified in the emergency department. Adjusted odds ratios (ORs) were compared for in-hospital mortality of patients who had received antibiotics within 1 h to that of those who did not. Spline regression models were used to assess the association of time-to-antibiotics as continuous variables and increasing risk of in-hospital mortality. The differences in the association between time-to-antibiotics and in-hospital mortality were assessed according to the presence of septic shock.

          Results

          Overall, 3035 patients were included in the analysis. Among them, 601 (19.8%) presented with septic shock, and 774 (25.5%) died. The adjusted OR for in-hospital mortality of patients whose time-to-antibiotics was within 1 h was 0.78 (95% confidence interval [CI] 0.61–0.99; p = 0.046). The adjusted OR for in-hospital mortality was 0.66 (95% CI 0.44–0.99; p = 0.049) and statistically significant in patients with septic shock, whereas it was 0.85 (95% CI 0.64–1.15; p = 0.300) in patients with sepsis but without shock. Among patients who received antibiotics within 3 h, those with septic shock showed 35% ( p = 0.042) increased risk of mortality for every 1-h delay in antibiotics, but no such trend was observed in patients without shock.

          Conclusion

          Timely administration of antibiotics improved outcomes in patients with septic shock; however, the association between early antibiotic administration and outcome was not as clear in patients with sepsis without shock.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found

          The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

          Definitions of sepsis and septic shock were last revised in 2001. Considerable advances have since been made into the pathobiology (changes in organ function, morphology, cell biology, biochemistry, immunology, and circulation), management, and epidemiology of sepsis, suggesting the need for reexamination.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

                Bookmark

                Author and article information

                Contributors
                suhgy@skku.edu
                Journal
                Crit Care
                Critical Care
                BioMed Central (London )
                1364-8535
                1466-609X
                13 January 2022
                13 January 2022
                2022
                : 26
                : 19
                Affiliations
                [1 ]GRID grid.264381.a, ISNI 0000 0001 2181 989X, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, , Sungkyunkwan University School of Medicine, ; Seoul, Republic of Korea
                [2 ]GRID grid.264381.a, ISNI 0000 0001 2181 989X, Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), , Sungkyunkwan University, ; Seoul, Republic of Korea
                [3 ]GRID grid.264381.a, ISNI 0000 0001 2181 989X, Department of Critical Care Medicine, Samsung Medical Center, , Sungkyunkwan University School of Medicine, ; Seoul, Republic of Korea
                [4 ]GRID grid.412480.b, ISNI 0000 0004 0647 3378, Department of Pulmonary and Critical Care Medicine, , Seoul National University Bundang Hospital, ; Seongnam, Republic of Korea
                [5 ]GRID grid.488421.3, ISNI 0000000404154154, Department of Pulmonary, Allergy and Critical Care Medicine, , Hallym University Sacred Heart Hospital, ; Anyang, Republic of Korea
                [6 ]GRID grid.267370.7, ISNI 0000 0004 0533 4667, Department of Pulmonary and Critical Care Medicine, Asan Medical Center, , University of Ulsan College of Medicine, ; Seoul, Republic of Korea
                [7 ]GRID grid.264381.a, ISNI 0000 0001 2181 989X, Department of Critical Care Medicine, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, , Sungkyunkwan University School of Medicine, ; 81 Irwon-ro, Gangnam-gu, Seoul, 06351 Republic of Korea
                Article
                3883
                10.1186/s13054-021-03883-0
                8756674
                35027073
                390a67ea-486f-4a8c-a9ec-001f9b1aa7ac
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 13 November 2021
                : 23 December 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100003669, Korea Centers for Disease Control and Prevention;
                Award ID: 2021-10-026
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Emergency medicine & Trauma
                sepsis,septic shock,time-to-antibiotics,hour-1 bundle,mortality
                Emergency medicine & Trauma
                sepsis, septic shock, time-to-antibiotics, hour-1 bundle, mortality

                Comments

                Comment on this article